Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Open Forum
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Open Forum
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
LetterCorrespondence

Neuromuscular Blocking Agents for ARDS: Incentive for Personalized Medicine

Heather Torbic, Sudhir Krishnan and Abhijit Duggal
Respiratory Care May 2021, 66 (5) 888; DOI: https://doi.org/10.4187/respcare.08963
Heather Torbic
Department of Pharmacy Cleveland Clinic Cleveland, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Sudhir Krishnan
Department of Critical Care Respiratory Institute Cleveland Clinic Cleveland, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhijit Duggal
Department of Critical Care Respiratory Institute Cleveland Clinic Cleveland, Ohio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Torbic H,
    2. Krishnan S,
    3. Harnegie MP,
    4. Duggal A
    . Neuromuscular blocking agents for ARDS: a systematic review and meta-analysis. Respir Care 2021;66(1):120–128.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Slutsky AS
    . Neuromuscular blocking agents in ARDS. N Engl J Med 2010;363(12):1176–1180.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.
    1. Gattinoni L,
    2. Marini JJ
    . Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: we are not sure. Intensive Care Med 2015;41(12):2201–2203.
    OpenUrl
  4. 4.↵
    1. Hraiech S,
    2. Forel JM,
    3. Papazian L
    . The role of neuromuscular blockers in ARDS: benefits and risks. Curr Opin Crit Care 2012;18(5):495–502.
    OpenUrlPubMed
  5. 5.↵
    1. Thompson BT,
    2. Chambers RC,
    3. Liu KD
    . Acute respiratory distress syndrome. N Engl J Med 2017;377(6):562–572.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Andrade C
    . The use and limitations of the fragility index in the interpretation of clinical trial findings. J Clin Psychiatry 2020;81(2):20f13334.
    OpenUrl
  7. 7.↵
    1. Ridgeon EE,
    2. Young PJ,
    3. Bellomo R,
    4. Mucchetti M,
    5. Lembo R,
    6. Landoni G
    . The fragility index in multicenter randomized controlled critical care crials. Crit Care Med 2016;44(7):1278–1284.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Cochrane Scientific Committee. Should Cochrane apply error-adjustment methods when conducting repeated meta-analyses? 2018. Available at: https://methods.cochrane.org/sites/default/files/public/uploads/tsa_expert_panel_guidance_and_recommendation_final.pdf. Accessed February 1, 2021.
  9. 9.↵
    1. Murray MJ,
    2. DeBlock H,
    3. Erstad B,
    4. Gray A,
    5. Jacobi J,
    6. Jordan C,
    7. et al
    . Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2016;44(11):2079–2103.
    OpenUrl
  10. 10.↵
    1. Papazian L,
    2. Aubron C,
    3. Brochard L,
    4. Chiche JD,
    5. Combes A,
    6. Dreyfuss D,
    7. et al
    . Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 2019;9(1):69.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Calfee CS,
    2. Delucchi K,
    3. Parsons PE,
    4. Thompson BT,
    5. Ware LB,
    6. Matthay MA
    . Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014;2(8):611–620.
    OpenUrl
  12. 12.↵
    1. Calfee CS,
    2. Delucchi KL,
    3. Sinha P,
    4. Matthay MA,
    5. Hackett J,
    6. Shankar-Hari M,
    7. et al
    . Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med 2018;6(9):691–698.
    OpenUrl
PreviousNext
Back to top

In this issue

Respiratory Care: 66 (5)
Respiratory Care
Vol. 66, Issue 5
1 May 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized Medicine
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized Medicine
Heather Torbic, Sudhir Krishnan, Abhijit Duggal
Respiratory Care May 2021, 66 (5) 888; DOI: 10.4187/respcare.08963

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Neuromuscular Blocking Agents for ARDS: Incentive for Personalized Medicine
Heather Torbic, Sudhir Krishnan, Abhijit Duggal
Respiratory Care May 2021, 66 (5) 888; DOI: 10.4187/respcare.08963
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board
  • Reprints/Permissions

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire